Biotechnology VALUE FUND II L.P., Insider at LIGAND PHARMACEUTICALS INC (LGND), bought 39,600 shares at $19.78 ($783K) on 2013-01-23, disclosed to the SEC on 2013-01-25.
Open-market purchase of $783k LGND by Insider. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.
| Filing → |
| THRD | BUY | 2022-12-22 | $1.7M | — | Filing → |
| KYMR | BUY | 2022-08-23 | $14.2M | — | Filing → |
| RPTX | BUY | 2022-06-15 | $3.8M | — | Filing → |